Table 1.
The relationships between ATF6 expression and clinical variables in patients with colon cancer (N = 165)
| ATF6 weak expression | ATF6 strong expression | P value | |
|---|---|---|---|
| n (%) | n (%) | ||
| Age (year) | |||
| ≤ 65 | 31 (44.3) | 42 (44.2) | 0.992 |
| > 65 | 39 (55.7) | 53 (55.8) | |
| Gender | |||
| Female | 21 (30.0) | 36 (37.9) | 0.292 |
| Male | 49 (70.0) | 59 (62.1) | |
| Location | |||
| Left colon | 40 (57.1) | 53 (55.8) | 0.862 |
| Right colon | 30 (42.9) | 42 (44.2) | |
| Stage AJCC VI | |||
| I | 11 (15.7) | 6 (6.3) | 0.007a |
| II | 30 (42.9) | 26 (27.4) | |
| III | 13 (18.6) | 37 (38.9) | |
| IV | 16 (22.9) | 26 (27.4) | |
| Pathology | |||
| Adenocarcinoma | 69 (98.6) | 94 (98.9) | 0.827 |
| Mucinous adenocarcinoma | 1 (1.4) | 1 (1.1) | |
| Grade | |||
| Low | 64 (91.4) | 84 (88.4) | 0.530 |
| High | 6 (8.6) | 11 (11.6) | |
| Lymphovascular involvement | |||
| No | 59 (84.3) | 73 (76.8) | 0.237 |
| Yes | 11 (15.7) | 22 (23.2) | |
| CIP2A expression | |||
| Weak | 56 (80.0) | 47 (49.5) | < 0.001a |
| Strong | 14 (20.0) | 48 (50.5) | |
a
P < 0.05.